Tazobactam Arginine Compositions
AssigneeCalixa Therapeutics, Inc.
InventorsJan-Ji Lai, Jian-Qiao Gu, Pradip M. Pathare, Valdas Jurkauskas, Joseph Terracciano, Nicole Miller Damour
Life of this patent
Estimating the term…
Abstract
This disclosure provides compositions containing solid forms of tazobactam arginine, and methods of manufacturing and using these compositions.
Claims25
A pharmaceutical composition comprising a compound having a beta-lactam chemical sub-structure and crystalline tazobactam arginine polymorph Ia.
A pharmaceutical composition obtained from a solution formed by dissolving a compound having a beta-lactam chemical sub-structure and crystalline tazobactam arginine polymorph Ia.
A pharmaceutical composition obtained by combining a compound having a beta-lactam chemical sub-structure selected from compounds in Table 2 and a tazobactam composition obtained from a solution formed by dissolving a crystalline tazobactam arginine polymorph Ia:
- TABLE 2
- No.
- IUPAC Name
- CAS No.
- 1
- (2S,5R,6R)-6-[(R)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-2-
- 61477-96-1
- phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-
- 2-carboxylic acid
- 2
- (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-
- 61-33-6
- zabicyclo[3.2.0]heptane-2-carboxylic acid
- 3
- (5R,6S)-6-[(1R)-1-hydroxyethyl]-3-({2-[(iminomethyl)amino]ethyl}thio)-
- 74431-23-5
- 7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
- 4
- (5R,6S)-6-((R)-1-hydroxyethyl)-7-oxo-3-((R)-tetrahydrofuran-2-yl)-4-thia-
- 106560-14-9
- 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid faropenem
- 5
- (2S,5R,6R)-6-{[3-(2-chlorophenyl)-5-methyl-oxazole-4-carbonyl]amino}-
- 61-72-3
- 3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
- 6
- (6R,7R,Z)-7-(2-(2-aminothiazol-4-yl)-2-(2-carboxypropan-2-
- 72558-82-8
- yloxyimino)acetamido)-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-aza-
- bicyclo[4.2.0] oct-2-ene-2-carboxylate
- 7
- (6R,7R,Z)-3-(acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-
- 63527-52-6
- (methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-
- carboxylic acid
- 8
- (6R,7R)-7-[(2Z)-2-ethoxyimino-2-[5-(phosphonoamino)-1,2,4-thiadiazol-
- 400827-46-5
- 3-yl]acetyl]amino]-3-[4-(1-methylpyridin-1-ium-4-yl)-1,3-thiazol-2-
- yl]sulfanyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 9
- (6R,7R,Z)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-
- 88040-23-7
- 3-((1-methylpyrrolidinium-1-yl)methyl)-8-oxo-5-thia-1-aza-
- bicyclo[4.2.0]oct-2-ene-2-carboxylate
- 10
- (6R,7R)-3-{[(aminocarbonyl)oxy]methyl}-7-{[(2Z)-2-(2-furyl)-2-
- 55268-75-2
- (methoxyimino) acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-
- 2-carboxylic acid
- 11
- (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-
- 73384-59-5
- (methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-
- 1,2,4-triazin-3-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-
- 2-carboxylic acid
- 12
- (2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)-acetyl]amino}-3,3-
- 26787-78-0
- dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
- 13
- 3-[5-(dimethylcarbamoyl) pyrrolidin-2-yl] sulfanyl-6-(1-hydroxyethyl)-4-
- 119478-56-7
- methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
A pharmaceutical composition comprising a tazobactam composition obtained from a solution formed by dissolving a tazobactam acid in an aqueous solution and lyophilizing the solution to obtain the tazobactam composition.
Dependencies are inferred from the claim text.